How Machine Learning and Statistical Models Advance Molecular Diagnostics of Rare Disorders Via Analysis of RNA Sequencing Data

Abstract

Rare diseases, although individually rare, collectively affect approximately 350 million people worldwide. Currently, nearly 6,000 distinct rare disorders with a known molecular basis have been described, yet establishing a specific diagnosis based on the clinical phenotype is challenging. Increasing integration of whole exome sequencing into routine diagnostics of rare diseases is improving diagnostic rates. Nevertheless, about half of the patients do not receive a genetic diagnosis due to the challenges of variant detection and interpretation. During the last years, RNA sequencing is increasingly used as a complementary diagnostic tool providing functional data. Initially, arbitrary thresholds have been applied to call aberrant expression, aberrant splicing, and mono-allelic expression. With the application of RNA sequencing to search for the molecular diagnosis, the implementation of robust statistical models on normalized read counts allowed for the detection of significant outliers corrected for multiple testing. More recently, machine learning methods have been developed to improve the normalization of RNA sequencing read count data by taking confounders into account. Together the methods have increased the power and sensitivity of detection and interpretation of pathogenic variants, leading to diagnostic rates of 10–35% in rare diseases. In this review, we provide an overview of the methods used for RNA sequencing and illustrate how these can improve the diagnostic yield of rare diseases.

Activation of Functional Somatic Stem Cells Promotes Endogenous Tissue Regeneration

“…Profiling the transcriptional level of stem cells at a defined condition using RNA-seq is a promising analysis to identify and prioritize genetic variants in the altered expression levels (Schlieben et al 2021). By using RNA-seq analysis, olfactory and growth factor pathways are identified as downstream targets of resveratrol in PDLSCs.…”

Metabolic Reconfiguration Activates Stemness and Immunomodulation of PDLSCs

“…Profiling the gene expression levels of stem cells under certain conditions by RNA-seq analysis is a promising and reliable approach to prioritize genetic variants [ 26 ]. In this study, RNA-seq analysis identifies that grow factor pathways, such as EGF and PDGF signaling, are the downstream targets of curcumin in PDLSCs.…”

Targeted RNAseq Improves Clinical Diagnosis of Very Early-Onset Pediatric Immune Dysregulation

“…The method in Cummings et al has been criticized for lacking a statistical basis and arbitrarily choosing cutoff thresholds [ 48 , 115 , 116 ]. Since publication, multiple tools for a robust statistical analysis for the identification of aberrant splicing have been developed, most notably FRASER [ 115 ].…”